ArticleMolecular biology reports2025
GDF15 attenuates myocardial hypoxic injury by inhibiting mitochondrial damage through BNIP3 pathway.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Mitokines as bioenergetic stress signals in cardiovascular disease: mitochondrial communication, endocrine adaptation, and translational implications.Journal of bioenergetics and biomembranes · 2026Review
- Adipokine-mediated metabolic responses across BMI in acute myocardial infarction.BMC cardiovascular disorders · 2026Article
- Radiation-induced autophagy regulates fibroblast mitochondrial metabolism and crosstalk with triple-negative breast cancer cells.Cell reports · 2026Article
- The Role of GDF-15 in Heart Failure and Biomarker Potential-From Basic Science to Clinical Praxis.Biology · 2026Review
- A Brief Description of the Cellular Mechanisms Involved in Cardiac Chemical Hypoxia.Cardiovascular toxicology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGrowth differentiation factor 15 (GDF15), a hypoxia-responsive mediator in myocardial injury, is established as a mitochondrial stress biomarker in skeletal muscle. However, its mechanistic role in regulating mitophagy during cardiac hypoxia remains unknown.
methodsIn this study, human myocardial cells (AC16) were treated with cobalt chloride (CoCl2) to induce hypoxia. GDF15 expression was analyzed using quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and Western blot. Cells were transfected with GDF15-knockdown lentivirus (LV-shGDF15) or overexpression lentivirus (LV-GDF15), and proliferation was monitored in real-time under normoxia or hypoxia using the iCELLigence RTCA DP and SP system. Mitochondrial function was assessed through lactate dehydrogenase (LDH) activity, superoxide dismutase (SOD) activity, malonaldehyde (MDA) concentration, cytosolic reactive oxygen species (ROS), mitochondrial transmembrane potential (ΔΨm), and oxygen consumption rate (OCR) analysis. To validate sequencing results, BCL2/Adenovirus E1B Interacting Protein 3(BNIP3) was knocked down using siRNA in LV-shGDF15 cells and overexpressed via plasmid in the LV-GDF15 group before evaluating ΔΨm and ROS. The effects on mitochondrial homeostasis were further assessed through RNA sequencing and mitochondrial functional analyses.
resultsThe proliferative ability of GDF15 knockdown cells was significantly decreased, accompanied by an increase in lactate dehydrogenase release. Overexpression of GDF15 significantly inhibited the accumulation of ROS and prevented ΔΨm loss. Administering GDF15 (50 ng/ml) to GDF15 knockdown cells effectively reduced MDA and ROS expression and mitigated ΔΨm loss. GDF15 protected AC16 cells from CoCl2-induced hypoxic injury. LV-shGDF15 cells with BNIP3 knockdown and CoCl2 treatment exhibited decreased levels of BNIP3 and LC3B-II, increased ΔΨm, and reduced ROS expression. Conversely, GDF15 overexpression significantly reduces BNIP3 levels, diminishes BNIP3-driven aberrant autophagosome biogenesis, and concurrently enhances lysosomal activity.
conclusionThis study unveils a novel cardioprotective mechanism of GDF15 through BNIP3 suppression and characterizes its temporal expression dynamics under hypoxia. GDF15 mitigates hypoxic injury by downregulating BNIP3, thereby curbing pathological mitophagy, activating lysosomes function, and offering a therapeutic target for ischemic cardiomyopathy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.